SLC6A4 and central nervous system cancer: TNF-α increases SERT activity and expression in glioma cell lines and primary astrocytes [40], while IL-1β stimulates SERT activity both in RN cell lines in vitro and synaptosomes in the frontal cortex, hippocampus, striatum, and midbrain of mice [41].